Author Bouter, Yvonne
-
2013 | Journal Article
P2–381: Tg4–42: A new mouse model of Alzheimer's disease—N‐truncated beta‐amyloid 4–42 affects memory decline and synaptic plasticity
Dietrich, K.; Bouter, Y.; Wittnam, J.; Pillot, T.; Papot‐Couturier, S.; Lefebvre, T. & Sprenger, F. et al. (2013)
Alzheimer's & Dementia, 9(4S_Part_12). DOI: https://doi.org/10.1016/j.jalz.2013.05.1030
Details DOI
-
2013 | Journal Article
P2–382: Tg4–42: A new mouse model of Alzheimer's disease—N‐truncated amyloid β (Aβ) 4–42 induces severe neuron loss and behavioral deficits
Bouter, Y.; Dietrich, K.; Wittnam, J.; Pillot, T.; Papot‐Couturier, S.; Lefebvre, T. & Sprenger, F. et al. (2013)
Alzheimer's & Dementia, 9(4S_Part_12). DOI: https://doi.org/10.1016/j.jalz.2013.05.1031
Details DOI
-
2013 | Journal Article |
N-truncated amyloid beta (A beta) 4-42 forms stable aggregates and induces acute and long-lasting behavioral deficits
Bouter, Y.; Dietrich, K.; Wittnam, J. L.; Rezaei-Ghaleh, N.; Pillot, T.; Papot-Couturier, S. & Lefebvre, T. et al. (2013)
Acta Neuropathologica, 126(2) pp. 189-205. DOI: https://doi.org/10.1007/s00401-013-1129-2
Details DOI PMID PMC WoS
-
2014 | Journal Article |
Deciphering the molecular profile of plaques, memory decline and neuron loss in two mouse models for Alzheimer's disease by deep sequencing
Bouter, Y.; Kacprowski, T.; Weissmann, R.; Dietrich, K.; Borgers, H.; Brauss, A. & Sperling, C. et al. (2014)
Frontiers in Aging Neuroscience, 6. DOI: https://doi.org/10.3389/fnagi.2014.00075
Details DOI WoS
-
2014 | Journal Article |
Abundance of Aß5-x like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer´s disease
Guzmán, E. A.; Bouter, Y.; Richard, B. C.; Lannfelt, L.; Ingelsson, M.; Paetau, A. & Verkkoniemi-Ahola, A. et al. (2014)
Molecular Neurodegeneration, 9(1) art. 13. DOI: https://doi.org/10.1186/1750-1326-9-13
Details DOI PMID PMC
-
2015 | Journal Article
Neuron Loss and Behavioral Deficits in the TBA42 Mouse Model Expressing N-Truncated Pyroglutamate Amyloid-beta(3-42)
Meissner, J. N.; Bouter, Y. & Bayer, T. A. (2015)
Journal of Alzheimer s Disease, 45(2) pp. 471-482. DOI: https://doi.org/10.3233/JAD-142868
Details DOI PMID PMC WoS
-
2015 | Journal Article |
Alzheimer therapy with an antibody against N-terminal Abeta 4-X and pyroglutamate Abeta 3-X
Antonios, G.; Borgers, H.; Richard, B. C. ; Brauss, A.; Meissner, J.; Weggen, S. & Pena, V. et al. (2015)
Scientific Reports, 5 art. 17338. DOI: https://doi.org/10.1038/srep17338
Details DOI PMID PMC WoS
-
2016 | Journal Article |
Endothelial LRP1 transports amyloid-beta(1-42) across the blood-brain barrier
Storck, S. E.; Meister, S.; Nahrath, J.; Meissner, J. N.; Schubert, N.; Di Spiezio, A. & Baches, S. et al. (2016)
Journal of Clinical Investigation, 126(1) pp. 123-136. DOI: https://doi.org/10.1172/JCI81108
Details DOI PMID PMC WoS
-
2016 | Journal Article
Gene Expression Profiling in the APP/PS1KI Mouse Model of Familial Alzheimer's Disease
Weissmann, R.; Huettenrauch, M.; Kacprowski, T.; Bouter, Y.; Pradier, L.; Bayer, T. A. & Kuss, A. W. et al. (2016)
Journal of Alzheimer s Disease, 50(2) pp. 397-409. DOI: https://doi.org/10.3233/JAD-150745
Details DOI PMID PMC WoS
-
2018 | Journal Article |
Synergistic Effect on Neurodegeneration by N-Truncated Aβ4-42 and Pyroglutamate Aβ3-42 in a Mouse Model of Alzheimer's Disease.
Lopez-Noguerola, J. S.; Giessen, N. M. E.; Ueberück, M.; Meißner, J. N.; Pelgrim, C. E.; Adams, J. & Wirths, O. et al. (2018)
Frontiers in aging neuroscience, 10 art. 64. DOI: https://doi.org/10.3389/fnagi.2018.00064
Details DOI PMID PMC
-
2019 | Journal Article |
Analysis of Motor Function in the Tg4-42 Mouse Model of Alzheimer’s Disease
Wagner, J. M.; Sichler, M. E.; Schleicher, E. M.; Franke, T. N.; Irwin, C.; Löw, M. J. & Beindorff, N. et al. (2019)
Frontiers in Behavioral Neuroscience, 13 art. 107. DOI: https://doi.org/10.3389/fnbeh.2019.00107
Details DOI
-
2019 | Journal Article |
18F-FDG-PET Detects Drastic Changes in Brain Metabolism in the Tg4–42 Model of Alzheimer’s Disease
Bouter, C.; Henniges, P.; Franke, T. N.; Irwin, C.; Sahlmann, C. O.; Sichler, M. E. & Beindorff, N. et al. (2019)
Frontiers in Aging Neuroscience, 10 art. 125. DOI: https://doi.org/10.3389/fnagi.2018.00425
Details DOI
-
2019 | Journal Article |
Reduced Acoustic Startle Response and Prepulse Inhibition in the Tg4-42 Model of Alzheimer’s Disease
Sichler, M. E.; Löw, M. J.; Schleicher, E. M.; Bayer, T. A. & Bouter, Y. (2019)
Journal of Alzheimer's Disease Reports, 3(1) pp. 269-278. DOI: https://doi.org/10.3233/ADR-190132
Details DOI
-
2019 | Journal Article |
Prolonged Cannabidiol Treatment Lacks on Detrimental Effects on Memory, Motor Performance and Anxiety in C57BL/6J Mice
Schleicher, E. M.; Ott, F. W.; Müller, M.; Silcher, B.; Sichler, M. E.; Löw, M. J. & Wagner, J. M. et al. (2019)
Frontiers in Behavioral Neuroscience, 13 art. 94. DOI: https://doi.org/10.3389/fnbeh.2019.00094
Details DOI
-
2021 | Journal Article |
Discovery of a novel pseudo β-hairpin structure of N-truncated amyloid-β for use as a vaccine against Alzheimer’s disease
Bakrania, P.; Hall, G.; Bouter, Y.; Bouter, C.; Beindorff, N.; Cowan, R. & Davies, S. et al. (2021)
Molecular Psychiatry,. DOI: https://doi.org/10.1038/s41380-021-01385-7
Details DOI
-
2021 | Journal Article | Research Paper |
Quantitative Brain Positron Emission Tomography in Female 5XFAD Alzheimer Mice: Pathological Features and Sex-Specific Alterations
Bouter, C.; Irwin, C.; Franke, T. N.; Beindorff, N. & Bouter, Y. (2021)
Frontiers in Medicine, 8. DOI: https://doi.org/10.3389/fmed.2021.745064
Details DOI
-
2022 | Journal Article
Small RNA Sequencing in the Tg4–42 Mouse Model Suggests the Involvement of snoRNAs in the Etiology of Alzheimer’s Disease
Lio, C. T.; Kacprowski, T.; Klaedtke, M.; Jensen, L. R.; Bouter, Y.; Bayer, T. A. & Kuss, A. W. (2022)
Journal of Alzheimer's Disease, pp. 1-11. DOI: https://doi.org/10.3233/JAD-220110
Details DOI
-
2022 | Journal Article |
Donanemab detects a minor fraction of amyloid-β plaques in post-mortem brain tissue of patients with Alzheimer’s disease and Down syndrome
Bouter, Y.; Liekefeld, H.; Pichlo, S.; Westhoff, A. C.; Fenn, L.; Bakrania, P. & Bayer, T. A. (2022)
Acta Neuropathologica, 143(5) pp. 601-603. DOI: https://doi.org/10.1007/s00401-022-02418-3
Details DOI
-
2023 | Journal Article |
Chronic exposure to a synthetic cannabinoid alters cerebral brain metabolism and causes long-lasting behavioral deficits in adult mice
Bouter, C.; Ott, F. W.; Günther, D.; Weig, L.; Schmitz-Peiffer, F.; Rozyyeva, M. & Beindorff, N. et al. (2023)
Journal of Neural Transmission,. DOI: https://doi.org/10.1007/s00702-023-02607-8
Details DOI
-
2024 | Journal Article | Erratum
Correction: Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N-truncted Abeta in sporadic Alzheimer disease cases and mouse models
Bouter, Y.; Noguerola, J. S. L.; Tucholla, P.; Crespi, G. A. N.; Parker, M. W.; Wiltfang, J. & Miles, L. A. et al. (2024)
Acta Neuropathologica, 147(1). DOI: https://doi.org/10.1007/s00401-024-02718-w
Details DOI